The Emerging Role for Zinc in Depression and Psychosis
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Zinc participation is essential for all physiological systems, including neural functioning, where it participates in a myriad of cellular processes. Converging clinical, molecular, and genetic discoveries illuminate key roles for zinc homeostasis in association with clinical depression and psychosis which are not yet well appreciated at the clinical interface. Intracellular deficiency may arise from low circulating zinc levels due to dietary insufficiency, or impaired absorption from aging or medical conditions, including alcoholism. A host of medications commonly administered to psychiatric patients, including anticonvulsants, oral medications for diabetes, hormones, antacids, anti-inflammatories and others also impact zinc absorption. Furthermore, inefficient genetic variants in zinc transporter molecules that transport the ion across cellular membranes impede its action even when circulating zinc concentrations is in the normal range. Well powered clinical studies have shown beneficial effects of supplemental zinc in depression and it important to pursue research using zinc as a potential therapeutic option for psychosis as well. Meta-analyses support the adjunctive use of zinc in major depression and a single study now supports zinc for psychotic symptoms. This manuscript reviews the biochemistry and bench top evidence on putative molecular mechanisms of zinc as a psychiatric treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926 · cited 2×
“Zinc and other antagonists of the NMDA receptor show antidepressant-like effects (Autry et al., 2011), attributed to FIGURE 2 | Zinc’s Impaired Ability to Act as a Neuromodulator.”
BackgroundDetection and interpretation of shared genetic influences on 42 human traits
Pickrell, J. K., Berisa, T., Liu, J. Z., Ségurel, L., Tung, J. Y., & Hinds, D. A. (2016) · Nature Genetics · doi:10.1038/ng.3570 · Cited by 1,151
Fukada, T., Civic, N., Furuichi, T., Shimoda, S., Mishima, K., Higashiyama, H., Idaira, Y., Asada, Y., Kitamura, H., Yamasaki, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003642 · Cited by 287 · cited 2×
“The SLC39 solute carrier genes are of particular interest, as recent research identified point mutations in association with severe mental illness (Ilouz et al., 2002; Fukada et al., 2008; Kranz et al., 2015).”
BackgroundA role for TGF-beta in oligodendrocyte differentiation.
McKinnon, R. D., Piras, G., Ida, J. A., & Dubois-Dalcq, M. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.6.1397 · Cited by 248 · cited 1×
“With respect to schizophrenia, the pathway regulates oligodendrocyte maturation and differentiation (McKinnon et al., 1993; Palazuelos et al., 2014).”
BackgroundZinc in depression: a meta-analysis
Swardfager, W., Herrmann, N., Mazereeuw, G., Goldberger, K., Harimoto, T., & Lanctôt, K. L. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.05.008 · Cited by 246
Mathews, D. C., Henter, I. D., & Zarate, C. A. (2012) · Drugs · doi:10.2165/11633130-000000000-00000 · Cited by 220 · cited 2×
“The World Health Organization predicts that by 2020 major depressive disorder will be the second leading cause of morbidity and mortality after ischemic heart disease (Mathews et al., 2012; WHO, 2012; Sowa-Kućma et al., 2013).”
BackgroundSiwek, M., Dudek, D., Paul, I. A., Sowa-Kućma, M., Zięba, A., Popik, P., Pilc, A., & Nowak, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.014 · Cited by 210 · cited 3×
“Several randomized controlled trials support the effectiveness of zinc as adjunctive therapy for improving mood in both depressed and healthy individuals (Nowak et al., 2003a; Siwek et al., 2009; Sawada and Yokoi, 2010; Lai et al., 2012; Ranjbar et al., 2014; Solati et al., 2015).”
BackgroundMethodSolati, Z., Jazayeri, S., Tehrani-Doost, M., Mahmoodianfard, S., & Gohari, M. R. (2015) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000105 · Cited by 104 · cited 2×
“Several randomized controlled trials support the effectiveness of zinc as adjunctive therapy for improving mood in both depressed and healthy individuals (Nowak et al., 2003a; Siwek et al., 2009; Sawada and Yokoi, 2010; Lai et al., 2012; Ranjbar et al., 2014; Solati et al., 2015).”
BackgroundRanjbar, E., Shams, J., Sabetkasaei, M., M-Shirazi, M., Rashidkhani, B., Mostafavi, A., Bornak, E., & Nasrollahzadeh, J. (2014) · Nutritional Neuroscience · doi:10.1179/1476830513y.0000000066 · Cited by 92
Vashum, K. P., McEvoy, M., Milton, A. H., McElduff, P., Hure, A., Byles, J., & Attia, J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.016 · Cited by 91 · cited 4×
“As pharmacotherapy is costly and comes with increased potential for adverse side-effects, zinc may serve as an adjuvant to help resolve symptoms of mental illness (Vashum et al., 2014; Mortazavi et al., 2015).”
BackgroundInfluential
Cited by
Recent aspects of the effects of zinc on human health
Chasapis, C. T., Ntoupa, P.-S. A., Spiliopoulou, C. A., & Stefanidou, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02702-9 · Cited by 702
Köhler, C. A., Evangelou, E., Stubbs, B., Solmi, M., Veronese, N., Belbasis, L., Bortolato, B., Melo, M. C. A., Coelho, C. A., Fernandes, B. S., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.05.020 · Cited by 302
Zinc and Central Nervous System Disorders
Wang, B., Fang, T., & Chen, H. (2023) · Nutrients · doi:10.3390/nu15092140 · Cited by 93
Nutrition and bipolar disorder: a systematic review
Gabriel, F. C., Oliveira, M., Martella, B. D. M., Berk, M., Brietzke, E., Jacka, F. N., & Lafer, B. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2077031 · Cited by 59
“Zinc is also often deficient in clinical populations, due to dietary insufficiency or pharmacological effects in its metabolism [109].”
BackgroundRisk factors for depression. New evidence on selenium deficiency and depressive disorders
Czaderny, K. (2020) · Psychiatria Polska · doi:10.12740/pp/112967 · Cited by 15
Donello, J. E., McIntyre, R. S., Pickel, D. B., & Stahl, S. M. (2025) · Pharmaceuticals · doi:10.3390/ph18020157 · Cited by 15
“Zinc has two binding sites on GluN2A subunits, one with high affinity and one with low affinity, and a third binding site on GluN2B subunits with lower affinity [28,30].”
Lye, M. S., Shahbudin, A.-F., Tey, Y. Y., Tor, Y. S., Ling, K. H., Ibrahim, N., Stanslas, J., Loh, S. P., & Rosli, R. (2019) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v2i3.34 · Cited by 4
“transporter genes, play a crucial role in zinc-glutamate homeostasis at the synaptic junction, which modulates the balance of excito-inhibitory impulses of the glutamatergic neurons [31,32].”
Background
Metadata
- Authors
- Petrilli, M. A., Kranz, T. M., Kleinhaus, K., Joe, P., Getz, M., Johnson, P., Chao, M. V., & Malaspina, D.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2017-06-30
- Volume
- 8
- Pages
- 414-414
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2625288402
- Cited by
- 124
- References
- 13
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.